Enhancing accessibility and impact of digitally enabled clinical trials: the WeShare engagement and equity toolkit

Digital technologies are advancing rapidly, reshaping the way we design, operate, and execute clinical trials. Digitally enabled trials are particularly well-positioned to accelerate the implementation of oncology research by streamlining key clinical trial processes such as screening, recruitment, consent, data collection, follow-up, and intervention delivery. Ensuring engagement and addressing equity concerns are critical to the success of these trials, especially if the goal is for digital health to act as an equalizer, reducing existing and persistent disparities in oncology care. This perspective emphasizes the development and implementation of a comprehensive toolkit to tackle engagement and equity challenges within digitally enabled clinical trials.